NCT02576223View on ClinicalTrials.gov

Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 27, 2018

Study Completion Date

August 27, 2018

Conditions
Pain
Interventions
DRUG

Ropivacaine hydrochloride

Ropivacaine injected perineural at the suprascapular nerve.

DRUG

Isotonic Saline

Saline injected perineural at the suprascapular nerve.

DRUG

PCA-pump

"PCA (Patient controlled analgesia) pump with the following settings:~Age \> 70 years or weight \< 60 kg: bolus dose 2,5 mg i.v. morphine, 15 minutes lockout Age \< 70 years and weight \> 60 kg: bolus dose 5 mg i.v. morphine, 15 minutes lockout Lockout time 15 minutes."

Trial Locations (2)

3400

Nordsjællands Hospital, Hillerød

4300

Holbæk Sygehus, Holbæk

All Listed Sponsors
lead

Kai Henrik Wiborg Lange

OTHER

NCT02576223 - Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery | Biotech Hunter | Biotech Hunter